Medistim — Earnings Release 2010

Oct 29, 2010

3. quarter results 2010 for MediStim ASA

Revenue for the 3rd quarter was MNOK 36.6 (MNOK 39.5)

with a profit before tax of MNOK 6.6 (MNOK 8.9). The

company has a strong cash flow from operation. Sales

through own sales organization was strong with a 13 %

volume growth in the US and 29 % volume growth in

Germany. During the quarter the company filed its

application to US FDA for VeriQC.